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Abstract
Background: Uganda is experiencing a shift in major causes of death with cases of stroke, heart attack, and heart
failure reportedly on the rise. In a study in Mukono and Buikwe in Uganda, more than one in four adults were
reportedly hypertensive. Moreover, very few (36.5%) reported to have ever had a blood pressure measurement. The
rising burden of CVD is compounded by a lack of integrated primary health care for early detection and treatment
of people with increased risk. Many people have less access to effective and equitable health care services which
respond to their needs. Capacity gaps in human resources, equipment, and drug supply, and laboratory capabilities
are evident. Prevention of risk factors for CVD and provision of effective and affordable treatment to those who
require it prevent disability and death and improve quality of life. The aim of this study is to improve health profiles
for people with intermediate and high risk factors for CVD at the community and health facility levels. The
implementation process and effectiveness of interventions will be evaluated.
Methods: The overall study is a type 2-hybrid stepped-wedge (SW) design. The design employs mixed methods
evaluations with incremental execution and adaptation. Sequential crossover take place from control to intervention
until all are exposed. The study will take place in Mukono and Buikwe districts in Uganda, home to more than
1,000,000 people at the community and primary healthcare facility levels. The study evaluation will be guided by; 1)
RE-AIM an evaluation framework and 2) the CFIR a determinant framework. The primary outcomes are implementation
– acceptability, adoption, appropriateness, feasibility, fidelity, implementation cost, coverage, and sustainability.
Discussion: The study is envisioned to provide important insight into barriers and facilitators of scaling up CVD
prevention in a low income context.
This project is registered at the ISRCTN Registry with number ISRCTN15848572.
The trial was first registered on 03/01/2019.
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Background
Cardiovascular disease and risk factors on the rise
Globally, approximately one third of all deaths are attrib-
uted to cardiovascular disease (CVD) [1]. In Europe,
CVD are estimated to be responsible for half of all
deaths causing more deaths than any other condition
[2]. Approximately, three quarters of all estimated global
deaths due to CVD take place in low and middle income
countries (LMICs) [3]. Moreover, it is projected that by
the year 2030, CVD alone will be responsible for more
deaths than infectious diseases (including HIV/AIDS,
tuberculosis, and malaria), maternal and perinatal condi-
tions, and nutritional disorders combined in LMICs [4].
The high and increasing burden of CVD in developing
countries is attributable to urbanization and higher
levels of risk factors, low age of manifestation, large
population sizes and the high proportion of young adults
[3]. The eight modifiable risk factors including: history
of hypertension or diabetes, obesity, unhealthy diet, lack
of physical activity, excessive alcohol consumption,
raised blood lipids and psychosocial factors are equally
on the rise especially in LMICs [5]. The main CVD
causing most death are heart failure, stroke, coronary
heart disease as well as renal complications.
Sub-Saharan Africa (SSA) is experiencing a rapid epi-
demiological transition [3] and Uganda in particular has
seen major causes of death shift from exclusively infectious
diseases to a combination of communicable and non-com-
municable diseases (NCDs) [6]. The first nationwide NCD
risk factor survey reported a prevalence of hypertension of
26.4%; 28.9% in urban and 25.8% in rural areas, among
whom only 7.7% were aware of their high blood pressure
status [7]. Authors allude that low awareness mirror a high
burden of undiagnosed and un-controlled high blood pres-
sure in the population [7]. In a study in central region fo-
cusing on Mukono and Buikwe districts, more than one in
four adults were reportedly hypertensive [8]. Moreover,
very few (36.5%) reported to have ever had a blood pres-
sure measurement [8]. In the same districts, a trend ana-
lysis of health facility data revealed increasing burden of
CVD at these facilities with cases of ischemic, rheumatic
and chronic heart diseases reportedly on the rise. Likewise,
stroke, hypertension and diabetes mellitus are on the rise
[9].
Preparedness of the healthcare system
The burden of CVD in LMICs is compounded by a lack of
integrated primary health care programs for early detection
and treatment of people with increased risk. As a result
many people in LMICs who suffer from CVD have less ac-
cess to effective and equitable health care services which re-
spond to their needs [10]. Consequently, many individuals
are detected late in the course of the disease and die youn-
ger from CVD, often in their most productive years. At the
household level, emerging evidence suggest that CVD are
contributing to poverty due to catastrophic health spending
and high out-of-pocket expenditure [10]. At the macro-eco-
nomic level, significant proportions of national health bud-
gets for LMICs are directed towards managing CVD.
Moreover, managing these conditions is a daunting task in
LMICs [10]. High burden of disease, socioeconomic bar-
riers and inequalities in access to treatment, suboptimal
staffing including shortage of physicians at health-care facil-
ities and limited capacity to conduct investigations are
widely documented as limiting factors [11–15].
In Uganda, the healthcare system is oriented to man-
age communicable diseases and this has not changed
significantly even with the changing trends in NCDs
[16]. A 2013 NCD needs assessment found that none of
the health facilities in Uganda met the World Health
Organization (WHO) standard for essential tools and
medicines needed to implement effective NCD interven-
tions [17]. Moreover, capacity gaps in human resources,
equipment, drug supply, and laboratory capabilities were
evident [17].
In Mukono and Buikwe districts, an assessment of the
health system capacity to care and manage hypertension
cases revealed a multitude of gaps both from the health
provider and patient perspectives. The health workers
highlighted that they had inadequate skills to manage
hypertension and its complications, lacked relevant
guidelines and equipment, were understaffed and the
health facilities they worked in frequently suffered stock
outs of antihypertensive [18]. The health workers also
reportedly noted that high costs, adherence challenges,
and transport problems affected patients uptake of
hypertensive services [18].
Interventions, strategies and models
Combination prevention of risk factors for CVD and
provision of effective and affordable treatment to those
who require it prevent disability and death and improve
quality of life. In the current study, we are drawing les-
sons from the HIV response in combination with the In-
novative Care for Chronic Conditions (ICCC)
framework to implement contextually appropriate inter-
ventions that address prevention of CVD in Mukono
and Buikwe districts in Uganda. The ICCC framework is
an adaptation of the chronic care model (CCM) but has
mainly been tested in high income countries [19]. The
framework expands the policy environment and puts
more emphasis on the role of the community, to enable
its applicability in a low income context [20]. A combin-
ation of both HIV/AIDS response models which enjoy
extensive application in SSA and the ICCC framework
provide synergies for a comprehensive study on CVD
prevention in a low income setting.
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Evidence for the proposed interventions, strategies and
models
Innovative HIV/AIDS response strategies have prevented
8 million deaths and 30 million new infections since
2000, and many of the worst-affected countries have
managed to cease—and in some cases, reverse—the
spread of the disease [21]. In SSA, a steady reduction in
HIV incidence and AIDS-related deaths is clearly docu-
mented [22]. Although the fight against HIV/AIDS is
not over and remains an important priority, the HIV/
AIDS response model provides unprecedented evidence
that chronic care in LMICs is feasible amidst scarce
resources. Successful HIV models [23] responsible for
the celebrated milestones in SSA have been tested in
several countries including Tanzania, South Africa,
Zambia, Uganda, and Malawi [22]. As reported by
Olmen and colleagues, the innovative responses are an
interplay of three pillars: a public health approach
(PHA); community and peer support; and strengthening
the health services in which care is embedded [22]. The
main principles of the PHA are simplification of treat-
ment protocols and clinical monitoring; decentralization
of ART care delivery to the local health centre and com-
munity level; and task shifting and involvement of com-
munity and people living with HIV (PLWHA) in
program design, management, and care [22]. In the
current project, we will borrow from these models to
implement a comprehensive package for prevention of
CVD. At the community, we train community health
workers (locally referred to as Village Health Teams
(VHTs) to conduct health education, risk assessments,
and motivational interviewing; facilitate creation of or
support strengthening of community networks; and pro-
mote cardiovascular health and education. At the pri-
mary healthcare level, we shall identify and train
non-physicians (mainly clinical officers/nursing staff ) to
screen for risk factors and provide basic care and man-
agement of CVD risk factors; train peers counsellors to
support patient follow-up, conduct peer counselling and
risk assessment; and provide basic buffer supplies to en-
sure continuity of CVD prevention and control services
at the level. We integrate a mobile and e-health compo-
nent to improve data capture, storage and patient
follow-up.
Study objectives and research questions
General objective
The general objective of the study is to implement an
enhanced CVD prevention program and evaluate the
implementation process and determine the effectiveness
on improving profiles for people with intermediate and
high risk factors for CVD at the community and health
facility levels.
Research questions
 How effective is an enhanced community approach
in improving population knowledge and screening for
CVD risk factors, referral and enhancing lifestyle
change in a real world setting versus usual care?
What is the uptake and what factors influence
implementation?
 How effective is an enhanced primary healthcare
approach in improving CVD risk profiles of patients
attending healthcare facilities? What is the uptake in
routine practice and what factors influence
implementation?
 What is the utility of an e-health screening tool in
profiling for CVD risk factors at the community and
at primary healthcare level? What is the uptake and
what factors influence implementation uptake?
 What is the impact of an enhanced comprehensive
CVD prevention program on patient outcomes
versus usual care?
Methods/design
Study design
The overall study is a type 2-hybrid stepped-wedge (SW)
design that emphasizes both clinical effectiveness and
implementation outcomes, with the eventual goal of
more rapid translation and uptake to usual care settings.
The design employs mixed methods with iterative im-
provement cycles [24]; and data collection entailing re-
peated measures at the community, household, health
facility and patient levels. The proposed design involve
incremental execution and adaptation and allows contin-
ued measurement of key process and outcome indicators
[24]. Sequential crossover take place from control to
intervention until all clusters are exposed (Fig. 1). The
core analyses will be qualitative and we will feed quanti-
tative data into these to further our understanding.
Context, study sites and sequencing
The study will take place in Mukono and Buikwe dis-
tricts, home to more than 1,000,000 people. The two
districts are largely rural with a significant proportion
(25%) living in urban or semi-urban neighbourhoods.
The districts share common boarders and lie along the
main transport corridor connecting Kampala (the capital
city) through Nairobi to Mombasa Sea Port in Kenya.
The districts are strategically located between the two
biggest urban areas of Jinja and Kampala. The preva-
lence of hypertension is high in these districts and only
35.6% of the adult general population have ever had
their blood pressure measured. More than one in four of
the general adult population are hypertensive [25] and
yet the health system is very weak to adequately care for
them [26]. This context provides an opportunity to
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scale-up proven, safe, efficient and cost-effective inter-
ventions to mitigate CVD risk factors. Mukono and
Buikwe districts together have 7 health sub districts, and
23 sub-counties (15 in Mukono and 8 in Buikwe). Re-
garding health facilities, the two districts have more than
126 health facilities of which 40.5% are government
owned, 41.3% are private for profit (PFP) and the rest
are private not for profit (PNFPs). Of the facilities, 5 are
hospitals (1 public), 4 health Centre IVs (3 public) and
23 are HCIIIs (20 public). For this study, 20 parishes
(Fig. 2) hosting the 20 public health centre IIIs in
Mukono and Buikwe will be included. From each Parish,
the HCIII is enrolled for the Health facility study and four
randomly selected villages are enrolled for the community
study. In the stepped wedge, five parishes are initially
assigned to the intervention (cycle 1) and the rest in usual
standard of care (control). Every 6 months, additional five
parishes (health facilities and villages) are switched to
intervention till all are exposed at the end of the 4 cycles.
We include Kawolo Hospital in Buikwe and Kojja and
Mukono HCIVs in Mukono to provide a referral mechan-
ism for complicated cases. Minimal support including
training is provided to these levels by the project.
Description of formative activities, and intervention plans
From October 2017, the study team conducted a situational
analysis of the CVD burden and contextual factors in
Uganda with a focus on Mukono and Buikwe districts. The
study revealed gaps (reported earlier) and a range of con-
textual recommendations to improve CVD prevention. The
recommendations from the analysis are summarized as
follows: empower lower level health facilities to manage
CVD and risk factors, utilize volunteers in screening for
CVD using non-laboratory means, utilize expert clients in
health promotion activities and peer support, institutionalize
peer model for care and management and improve data
capture for CVD and create database.
Drawing from the recommendations and in the con-
text of global literature on best practices (reported earl-
ier), we propose to advance CVD prevention along the
cascade through health promotion and education and
screening for risk factors at the community (community
plan) and strengthen health services at the primary
healthcare level (Primary healthcare plan) in Mukono
and Buikwe district in Uganda. This study is part of a
bigger project code named “SPICES”. SPICES is an acro-
nym for Scaling up Packages of Interventions for Car-
diovascular disease prevention in selected sites in
Europe and sub-Saharan Africa. The partners imple-
menting SPICES and their respective countries are: Uni-
versity of Antwerp, Belgium (Coordinator); Brighton and
Sussex Medical School and Nottingham Trent Univer-
sity, both in the United Kingdom; Brest University in
France, and the University of Limpopo in South Africa.
Primary healthcare plan
Facilities in the intervention cycle(s) are strengthened
with certain aspects to improve screening, diagnosis and
management of risk factors for CVD. These aspects in-
clude: supplies and equipment such as blood pressure
(BP) monitoring devices, glucometers and buffer stock
for first line anti-hypertensive medicines; guidelines and
Fig. 1 Illustration of a stepped-wedge study design with periodic surveys every 6 months
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standardized treatment protocols; computers and digital
devices to improve data capture and storage; and train-
ing health workers and patients peers. Health workers
are trained based on a manual adopted with modification
from the Uganda Ministry of Health training manuals and
others materials on Non communicable diseases. Trained
health workers are equipped with a simplified algorithm
(adopted with modification from the hearts and the WHO
PEN protocols and the Uganda Clinical guidelines) to
guide them in screening, diagnosis and managing the risk
factors. Meanwhile, peers are equipped with knowledge
and skills to conduct peer counselling, support screening
activities and follow-up of patients.
Community plan
The community plan revolves around working with
community health workers (VHTs), existing networks
and community structures to promote knowledge, im-
proved lifestyles, risk assessment and cardiovascular
health. CHWs are trained to conduct health education,
promote lifestyle change through motivational interview-
ing and goal setting techniques, screen for risk factors at
Fig. 2 Map of Mukono and Buikwe showing selected parishes for the stepped wedge study
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the community using non laboratory tools, and conduct
home to home visits. Existing community networks and
community structures are identified and supported to
promote improved lifestyle behaviours, screening for risk
factors and cardiovascular health education and promo-
tion. Electronic and print media (messages) are circu-
lated to enhance health promotion and improved
lifestyle behaviours.
Data capture and information management
To enhance data capture and information management
and storage, both the community and health facility
plans are supported with an e-health and mobile health
platforms. The electronic plan will be explored to under-
stand its contribution in improving data management
and screening for CVD risk factors, enhancing linkage
and referral as well as triggering behaviour change. Elec-
tronic enhancement entail mounting data capture and
screening tools on a mobile/computer platform and used
for registration, risk assessment and where possible link-
ing/confirming linkage of participants for service.
Evaluation plan
To evaluate the study, we propose to conduct a series of
cross-sectional surveys every 6 months at time (T) 0, T6,
T12, T18 and T24 at the community and health facility
levels. We assess with key community and household
members, health facilities, health workers, and patients.
The evaluations uses both: qualitative assessments – to
evaluate the process, barriers and opportunities; and quan-
titative measurements – to assess effects and process
outcomes. During the interventions, formative processes
(process evaluations) and detailed documentation of
process, costs and activities take place.
Inclusion and exclusion
Inclusion
 Both male and female
 Aged 18 years and above
 Consent to participate in the study
Exclusion
 The mentally ill will not be included in the
evaluations
 Non consenting adults
Sample size and sampling
Community quantitative surveys
For the community series of cross sectional surveys, we
adopt the formula by Hemming et al. 2016 for cross sec-
tional sample size determination for a stepped wedge
study. To determine a moderate effect size of 0.3 (SD 1)
for say change in Blood pressure at 5% significance, and
detectable power of 88%, before and after the exposure
to the intervention, given a sample size that is feasible
and realistic in these setting, with four (4) steps and five
(5) clusters per step, a total sample size of 50 partici-
pants per cluster is assumed reasonable [27]. However,
assuming an intracluster correlation coefficient, r, of
0.01, a fixed cluster sample size, m = 50, survey rounds,
t = 5 and a design effect of 2.93 [27] with 20 predeter-
mined clusters; the required total sample size per survey
round is 2930 households. We recognise that a random
sample of household in a vast geographic setting can re-
turn a lot of non-responses. Thus, to cater for
non-responding households and to avoid replacement of
randomly selected eligible households, we factor in a
non-response of 30% and generate the final household
sample of 4000; with each cluster contributing 200
households. Sampling households and participants: The
sampling frame for the surveys is generated through a
mapping and listing exercise. All households in the
catchment area are assigned a unique number to gener-
ate a sampling frame. A random sample of 200 eligible
households with at least one adult per household is gen-
erated from the sampling frame using a random number
generator. The selection is conducted by the study statis-
tician. Study personnel (trained research assistants)
approach the selected households for recruitment into
the household/community survey. When a selected
household is approached and has at least one eligible
adult, study personnel describe the purpose of the study
in the appropriate language, obtain participant consent
and administer the study questionnaire and conduct an-
thropometric and blood pressure measurements using
standardised and validated equipment. All eligible adults
in the household aged 25–70 years are enrolled.
Health facility surveys
All Health centre IIIs are assessed for readiness and cap-
acity to provide care for CVD prevention and control. The
assessment is conducted with a quantitative questionnaire
adapted with modification from the World Health Organ-
isation service availability and readiness assessment
(SARA) instrument. The tool is administered to the facil-
ity/unit heads to capture the relevant information on
CVD prevention, service availability and readiness and
staffing. In addition, health workers’ knowledge, practices
and attitudes are assessed to generate relevant skill and
knowledge gaps during pre and post training assessments
using a health workers questionnaire. All health workers
enrolled for training participate in these evaluations. Fur-
thermore, a purposive sample of health workers partici-
pate in qualitative evaluations to assess organizational
readiness for change, including perceived barriers to
change, acceptability, feasibility, and appropriateness of
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implementing the enhanced program at the health facility.
The required sample size is informed by the principal of
data saturation in qualitative research. For readiness of the
community component, CHWs are assessed with a ques-
tionnaire to document their current knowledge, practices
and attitudes on prevention of CVDs. In addition, perceived
barriers to change, acceptability, feasibility, and appropriate-
ness of implementation is explored qualitatively to garner
CHWs perspectives. We also plan to conduct focus group
discussions with community members and key informant
interviews to assess community attitudes, perceptions, ac-
ceptability and appropriateness of community interventions
and strategies. Similarly, an appropriate number of FGDs is
determined based on principle of information saturation,
geographical diversity, age distribution and gender and
other parameters deemed relevant. Patient surveys – To
generate information on the health status of the patients,
quality of life, satisfaction, challenges, adherence practices
and support mechanisms, proportion of screened patients
at health facilities, a survey of patients is conducted using a
patient assessment questionnaire.
Study outcomes and evaluation framework
Primary outcome
Implementation (Reach, Appropriateness, Acceptability,
Self-efficacy, Adoption, Cost, Feasibility, Fidelity and
Sustainability).
Secondary outcome
Effectiveness (Change in selected profiles e.g. knowledge,
blood pressures, waist hip ratio/BMI, alcohol history,
smoking status, quality of life, etc.).
Evaluation frameworks
We propose to evaluate the project guided by two validated
and widely used implementation frameworks 1) RE-AIM,
an evaluation framework and 2) the Consolidated Frame-
work for Implementation Research (CFIR), a determinant
framework [28–32]. The broader implementation outcomes
as proposed by Proctor and colleagues [33] —acceptability,
adoption, appropriateness, feasibility, fidelity, implementa-
tion cost, coverage, and sustainability are pre-determined in
order to understand the factors affecting the implementa-
tion, the processes, and the accruing results. The RE-AIM
and CFIR frameworks are selected based on a review of
literature that demonstrate that they are suitable for a com-
plex intervention. The RE-AIM (Reach, Effectiveness,
Adoption, Implementation and Maintenance) framework
offers a comprehensive structure designed to systematically
assess the robustness of interventions across settings and
individual subgroups and the potential for their scaling up
and spread to additional settings [30]. Reach, the percent
and representativeness of individuals willing to participate;
Effectiveness, the impact of the intervention on targeted
outcomes and quality of life; Adoption, the per cent and rep-
resentativeness of settings and intervention staff that agree
to deliver a program; Implementation, the consistency and
skill with which various program elements are delivered by
various staff; and Maintenance, the extent to which individ-
ual participants maintain behaviour change long term and,
at the setting level, and the degree to which the program is
sustained over time within the organizations delivering it
(www.re-aim.org). The CFIR is an implementation frame-
work that allows for systematic evaluation of barriers and
facilitators that may impact the adoption, implementation,
and/or maintenance of a program [34–36]. It provides a
useful template for organizing key concepts in implementa-
tion research. A detailed description of the framework is
available elsewhere [34, 36]. Some elements of this frame-
work will be used to guide data collection (both qualitative
and quantitative), and analysis of the contextual factors that
have potential to impact the implementation of the project.
The CFIR Research Team provides resources to guide im-
plementation evaluation (https://cfirguide.org/). In Table 1
we present a detailed process evaluation guide checklist that
we have adopted with modifications of the frames to meas-
ure the delivery of the intervention and the evaluation
process. Pre-implementation, implementation and post im-
plementation processes of the intervention are foreseen
using mixed methods [28].
Data management and quality control
The study coordinator will be responsible for all data
collection instruments and their transportation to and
from the study sites in Mukono and Buikwe and back to
Makerere University School of Public Health (MakSPH).
The study instruments are either paper based or elec-
tronic collected with android enabled phones and tablets
using REDCap. All data (paper based or electronic) be-
fore submission to MakSPH is field edited for accuracy
and consistency. Clean electronic data will be synchro-
nized by the field team and uploaded to the MakSPH
server on a daily basis. All qualitative data will be audio
recorded and transcribed verbatim and then securely
stored at MakSPH. Qualitative audio transcript shall also
be edited, coded and analysed at MakSPH. Completed
paper based forms shall be converted to electronic
through data entry at MakSPH. To ensure quality of
data collected, the coordinator is supported by two field
supervisors/data quality controllers to provide day to
day support and supervision of the data collection exer-
cise. The supervisors check progress and quality of work,
clarify questions on study instruments, and supply add-
itional study instruments and stationery, and advice on
how to solve logistical problems. Further quality assur-
ance and fidelity checks are conducted by the study in-
vestigators on a monthly or more regular basis.
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Data analysis
Qualitative data will be analysed using the framework
analysis technique, which facilitates thematic analysis.
The quantitative analyses will be guided by the
principle of intention-to-treat and clusters analysed ac-
cording to their randomised crossover time irrespective
of whether crossover was achieved at the desired time.
The analysis will be conducted in Stata or R Software.
Initially, descriptive analysis (before and after) will be
conducted and categorical data presented using counts
and percentages, while continuous variables presented
using measures of central tendencies. No multiple impu-
tations will be conducted for missing data. The following
descriptive are envisioned.
1. Reach of the project, captured through: the number
and percentage of providers and individuals enrolled
into the project at the community and health facility
levels; the number of individuals partaking and
adhering to the recommended interventions at the
various levels.
2. Effectiveness: Activities and clinical endpoints will
be used to assess effectiveness of the project at
selected intervals observed longitudinally. The
measures include: the proportion of project activities
(community/health facilities) achieved at any point
in time; change in clinical profiles e.g. blood pressures,
BMI, alcohol history, smoking status, quality of life
etc., achieved at 0, 6, 12, 18 and 24months; and
proportion of completers and attritors.
3. Adoption: The number/percentages of individuals/
providers approached or agreed to take part in the
intervention (s) and proportion of individual
providers (CHW, Peers or NPHW) that deliver the
intervention.
4. Implementation: Captured by detailed description
of the contextual adaptations of the project, the
time required for intervention, and the costs of the
Table 1 Evaluation framework for both the Community/Health facility Strategy
Primary outcomes - (Reach, Appropriateness, Acceptability, Self-efficacy, Adoption, Cost, Feasibility, Fidelity and Sustainability)
Implementation
outcome
Description Measurement Time points
Reach Proportion of the health care/community providers/
target population approached; Uptake of intervention
packages; and proportion of adherent
Analysis of routine data generated by CHW, peers &
Health facilities and individual/patients quantitative
assessments using household/patient questionnaires
0, 6, 12, 18 and 24
months
Appropriateness The extent to which proposed interventions can be
delivered at health facilities/community
Individual interviews Focus group discussion,
Key informant interviews
0, 6, 12, 18 and 24
months
Organizational Readiness Availability and functionality of infrastructure
including personnel, equipment, supplies etc.
measured using the Health facility readiness
and capacity assessment questionnaire
0, 6, 12, 18 and 24
months
Linkage to healthcare 1. Self-report using h/h questionnaire,
2. Data extraction checklist
12 and 24 months
Referrals for task sharing/shifting Data extraction checklist 12 and 24 months
Acceptability User and provider feedback Focus group discussions guides
Key informants
Formative process
ongoing
Individual/Patient satisfaction (Needs) Patient Satisfaction Questionnaire 12 and 24 months
Self-efficacy Personnel beliefs about own competencies to
achieve implementation goals
Provider questionnaire
Pre/post training assessment tools
12 and 24 months
Adoption Implementation of the project and challenges to
implementation (Barriers and opportunities and
coping mechanisms).
Focus group discussions and individual interviews
Key informant interviews
0, 6, 12, 18 and 24
months (formative
process ongoing)
Cost Costs associated with implementing the packages Checklists for cost data (Health facility cost data
related to the project
Community program cost data)
12 and 24 months
Feasibility Exposure to and retention of the enhanced
interventions e.g. CVD education, counseling etc.
Data extraction checklist (Daily activities conducted
related to the enhanced interventions e.g. counselling,
no. of people profiled, followed up etc.)
12 and 24 months
Fidelity The extent to which providers are delivering
packages as per the protocol/guidelines
Observer rating forms Formative process
ongoing
Sustainability The extent to which the program is being
implemented as a standard of practice
Key informant interviews with providers. 12 and 24 months
Secondary outcomes – Effectiveness (Change in selected profiles e.g. knowledge, blood pressures (diastolic blood pressure), waist hip ratio/BMI,
alcohol history, smoking status, etc.) measured at T 0,6,12,18 and 24month using surveys.
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intervention. Implementation information including
process, facilitators and barriers, costs, and contextual
issues will be analysed descriptively and qualitatively.
Readiness of implementation (Available resources) –
BP monitoring devices, Weighing scales,
Stadiometers, measuring tapes, Glucometers and
strips, first line antihypertensive drugs, guidelines,
personnel, space, time etc. will be descriptively
described and presented using graphs. Quality and
quantity of equipment and their functionality,
supplies and other necessary infrastructure will be
descriptively analysed. Fidelity – Evidence of use of
guidelines and protocols/simplified algorithm and any
iterations recorded will be analysed descriptively and
qualitatively. Costs - Costs associated with
implementing the packages. Monetary requirements
for each intervention (community and health facility
based) will be analysed descriptively as a measure of
sustainability based on feedback reports from
community members, patients, CHWs, health unit
staff and project and field coordinators.
5. Maintain: The extent to which the project becomes
part of routine practice and policy will be explored.
Evaluation of maintenance will include the following:
Analysing the proportion of health providers who are
introduced to the enhanced approach and those
adapting the strategies.
Paired t-tests will be run to compare means across
clusters and within clusters. However, given the time
trend and clustering effects, we proceed to adjust for dif-
ferent observation periods and for clustering in the data
by fitting an appropriate generalised linear mixed model
or using generalised estimating equations. For continu-
ous (and normally distributed) outcomes, we fit a linear
model with random effect for cluster and fixed effect for
each step; and, for binary outcomes, a logistic regression
model with random effect for cluster and fixed effect for
each step.
Discussion
The study is envisioned to provide important insight
into effectiveness and barriers and facilitators of uptake
of CVD prevention at the community and health facility
levels in a low income context. The project will utilize
both the Green Open Access and Gold Open Access
model to disseminate and publish research data. Dissem-
ination workshops and meetings will be organized at the
local, national and international platforms. We will use
available institutional repository to archive anonymised
data. The project is the beginning of a long intervention
programme which aim to translate the research findings
including tested models into routine implementation.
Trial status
The trial has received both approvals from the Makerere
University Higher Degrees Research and Ethics and the
Uganda National Council of Science and Technology.
Permission to conduct the trial has also been obtained
from both districts – Mukono and Buikwe. Currently, a
baseline survey is ongoing and intervention start in the
first quarter of 2019. The trial is registered with ISRCTN
registry, number ISRCTN15848572.
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